Trump’s 100% Tariff Hike: Sun Pharma Leads Pharma Stocks Decline
Sun Pharmaceutical Industries Ltd. declines nearly 5% as Trump announces 100% tariff on the Pharmaceutical sector, affecting Indian pharma stocks and US trade relations.
Sensex
Epack Durable Shares Get a Bullish ‘Buy’ Rating from Yes Securities with 44% Upside Potential
Epack Durable Ltd. has received a ‘Buy’ rating from Yes Securities, citing its strong value proposition, robust manufacturing capabilities, and improving margin trajectory. The research firm sees a 44% upside potential in the stock.
Rites Stock Price Surges: What’s Behind the Rally and What It Means for Indian Investors
Rites Ltd. has seen a significant surge in its stock price following a key international order win in South Africa. What does this mean for Indian investors and the company’s future prospects?
GK Energy IPO Listing: Shares Debut at 12% Premium, What’s Next for Investors?
GK Energy Ltd. shares listed at a 12% premium over the IPO price, with the scrip opening at Rs 171 on the NSE and Rs 165 on the BSE. What does this mean for investors and the future of the company?
Accenture’s Q4 Results: What Indian IT Companies Can Expect
Motilal Oswal’s report on Accenture’s Q4 results and its implications for Indian IT companies, including expected revenue growth and challenges in the industry.
Hindustan Aeronautics: A Defensive Gem in the Indian Stock Market
Hindustan Aeronautics Ltd. has received a follow-on order worth Rs 624 billion from the Ministry of Defence, reinforcing its position in the Indian stock market. Get the latest updates and analysis on HAL’s prospects.
Fusion Gets ‘Buy’ Upgrade From Motilal Oswal: What Indian Investors Need to Know
Motilal Oswal upgrades Fusion to ‘Buy’ while downgrading Spandana to ‘Neutral’ in the MFI space. Understand the implications for Indian investors and the broader NBFC-MFI sector.
Godrej Agrovet Shares: 42% Upside Potential as per ICICI Securities
Godrej Agrovet shares have a significant upside potential of 42% according to ICICI Securities, driven by robust growth in earnings and improvements in realisations and margins.
Tariff Shock: Will Indian Markets Feel the Heat?
Expert analysis on the impact of US tariffs on Indian markets, including the pharmaceutical sector and potential opportunities for investors.
TCS Share Price Hits Over Four-Year Low: Understanding the Key Factors
Tata Consultancy Services (TCS) share price has declined substantially, reaching an over four-year low. Find out the key factors contributing to this downtrend and its implications for Indian investors.